What it is
Resting heart rate is your beats per minute at complete rest — a window into cardiovascular fitness and autonomic tone.
Why it matters for longevity
The engine is a constructed PCHIP (70 bpm = 1.0; 40–50 floor 0.85; ≤60 target = 0.90). Near 60–80 bpm it tracks Zhang 2016’s general-population ACM RR 1.09 (1.07–1.12) per 10 bpm (46 studies; 1.25 million people; I² 92.3%) — that is a relative risk, not a hazard ratio, and it is an association, not a treatment effect. Zhang’s trim-and-fill for publication bias is RR 1.04 (1.02–1.06). ACM versus 45 bpm is linear (p nonlinearity = 0.1); the 90 bpm mark is cardiovascular mortality, not an all-cause cliff. Above 80 the engine steepens past Zhang’s linear slope (1.25 at 90 vs ~1.19). Overlay: Zhang. Under: Aune 2017 (meta — larger ACM pool RR 1.17 per 10 bpm, mixed prospective) / Raisi-Estabragh 2020 (competing — UKB per 10 bpm ACM 1.22 men / 1.19 women) / Custodis 2016 (action — ≥70 vs <70 ACM 1.68, coronary events NS; marker, not a rate-lowering trial). Engine not moved.
How to improve it
- Build aerobic fitness (it lowers resting HR over time)
- Prioritize sleep and keep caffeine earlier in the day
- Practice breathing or meditation for recovery
Evidence, by endpoint
| Endpoint | Grade | Finding |
|---|---|---|
| — | METHOD | PCHIP is constructed (70 bpm = 1.0) Knots 40/50 = 0.85, 60 = 0.90, 70 = 1.0, 80 = 1.10, 90 = 1.25, 100 = 1.40, 120 = 1.60. Near 60–80 this is ~Zhang’s +9%/10 bpm. Steeper than Zhang above 80. Engine not moved. |
| All-cause mortality | B | Zhang 2016 is RR 1.09, not an HR General-population ACM RR 1.09 (1.07–1.12) per 10 bpm. Trim-and-fill 1.04. 90 bpm is the CV spline vs 45 bpm — ACM is linear. Aune 2017 ACM RR 1.17 is the larger pool. Custodis: ≥70 bpm predicts ACM, not coronary events. |
| All-cause mortality | B | 1.22 / 1.19 in UK Biobank (Raisi-Estabragh 2020) Single cohort, 502,534 UK Biobank adults, seated Omron pulse (mean of two readings) — closer to a home reading than Zhang’s mixed ECG pool. Fully adjusted ACM HR per 10 bpm: 1.22 (1.20–1.24) in men, 1.19 (1.16–1.22) in women, both higher than Zhang’s pooled 1.09. |
| All-cause mortality | B | 1.17 Per 10 bpm, a Larger Pool (Aune 2017) Larger dose-response meta than Zhang: 48 studies pooled ACM RR 1.17 (1.14–1.19) per 10 bpm, I² 94.0%. The high-vs-low contrast in the same paper was RR 1.69 (1.52–1.87) — both higher than Zhang’s pooled 1.09, from a broader prospective mix than Zhang’s general-population-only pool. |
| All-cause mortality, middle-aged men only | C | Significant Only in Middle-Aged Men (Okamura 2004) Japanese general-population cohort of 8,800 adults followed 16.5 years: middle-aged men (30–59) in the highest resting-heart-rate quartile had 45% higher all-cause mortality (RR 1.45, 95% CI 1.06–2.00) than lower quartiles, but the association was not significant in adults 60 and older. |
| All-cause mortality | B | Predicts Death, Not Coronary Events (Custodis 2016) Heinz Nixdorf RECALL cohort, 4,091 adults free of known CAD and off rate-lowering medication, median 10.5 years, 398 deaths: RHR ≥70 vs <70 bpm carried ACM HR 1.68 (1.30–2.18), and per 5 bpm ACM HR 1.13 (1.07–1.20) — but the same slices showed no significant association with coronary events (HR 1.20 and 1.02, both NS). |
What argues against this
Raisi-Estabragh et al. 2020 (slot: competing), a single UK Biobank cohort of 502,534 adults using seated Omron pulse readings — closer to a home reading than Zhang's mixed ECG pool — found a steeper all-cause mortality slope per 10 bpm than the engine's Zhang-anchored baseline: HR 1.22 (1.20–1.24) in men and 1.19 (1.16–1.22) in women versus Zhang's pooled 1.09. This argues the engine's near-baseline slope may understate resting-heart-rate risk rather than overstate it — a magnitude disagreement, not a directional one.
Last reviewed 2 September 2026
Evidence
- Zhang et al. (2016) — CMAJResting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysisView source
- Aune et al. (2017) — Nutrition, Metabolism and Cardiovascular DiseasesResting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality – A systematic review and dose-response meta-analysis of prospective studiesView source
- Raisi-Estabragh et al. (2020) — PLoS ONEAge, sex and disease-specific associations between resting heart rate and cardiovascular mortality in the UK BIOBANKView source
- He et al. (2022) — Public HealthRelationship of resting heart rate and blood pressure with all-cause and cardiovascular disease mortalityView source
- Okamura et al. (2004) — American Heart JournalResting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general populationView source
- Custodis et al. (2016) — Clinical Research in CardiologyResting heart rate is an independent predictor of all-cause mortality in the middle aged general populationView source
Educational content only — not medical advice, diagnosis, or treatment. Not a medical device; not FDA evaluated. Consult a qualified healthcare professional about your own health, and call emergency services for urgent symptoms. Full medical disclaimer →